November 4, 2013 A company subsidiary pleaded guilty to a misdemeanor charge stemming from the promotion of antipsychotic Risperdal for the treatment of dementia in elderly patients. The Food and Drug Administration never approved the drug for that use.
August 15, 2012 The health products giant affirmed the safety of the chemicals in question but acknowledged that hasn't been enough to satisfy some critics. The chemicals on the way out range from triclosan, an antibacterial ingredient, to others that release small amounts of formaldehyde.
April 11, 2012 An Arkansas judge's penalty is just the latest legal setback related to the company's marketing of Risperdal, an antipsychotic drug. Among the drug's possible side effects are weight gain and increased risk for diabetes.
February 17, 2012 A newly designed bottle and syringe that were supposed to make it easier to give a baby the right dose of Tylenol have drawn complaints from parents. The system is too difficult to use.